Green Cross (005250) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Green Cross (005250) total liabilities for a breakdown of total debt and financial obligations.

Green Cross Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Globe Trade Centre S.A.
WAR:GTC
0.027x
Xinjiang Talimu Agriculture Development Co Ltd
SHG:600359
-0.010x
J.Kumar Infraprojects Limited
NSE:JKIL
0.129x
Meihua International Medical Technologies Co Ltd
NASDAQ:MHUA
-0.120x
American Battery Technology Company Common Stock
NASDAQ:ABAT
-0.082x
Camil Alimentos S.A
SA:CAML3
0.102x
Orient Electric Limited
NSE:ORIENTELEC
-0.059x
First Copper Technology Co Ltd
TW:2009
0.033x

Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩1.85 Trillion
≈ $1.26 Billion
₩-89.95 Billion
≈ $-60.96 Million
-0.049x -130.42%
2023-12-31 ₩1.88 Trillion
≈ $1.28 Billion
₩-39.65 Billion
≈ $-26.87 Million
-0.021x -142.67%
2022-12-31 ₩1.97 Trillion
≈ $1.33 Billion
₩97.16 Billion
≈ $65.84 Million
0.049x -9.05%
2021-12-31 ₩1.91 Trillion
≈ $1.29 Billion
₩103.77 Billion
≈ $70.32 Million
0.054x +154.07%
2020-12-31 ₩1.67 Trillion
≈ $1.13 Billion
₩35.77 Billion
≈ $24.24 Million
0.021x +320.95%
2019-12-31 ₩1.51 Trillion
≈ $1.02 Billion
₩7.65 Billion
≈ $5.18 Million
0.005x -80.40%
2018-12-31 ₩1.45 Trillion
≈ $984.76 Million
₩37.64 Billion
≈ $25.51 Million
0.026x -74.19%
2017-12-31 ₩1.44 Trillion
≈ $975.64 Million
₩144.48 Billion
≈ $97.91 Million
0.100x +17256.99%
2016-12-31 ₩1.38 Trillion
≈ $933.18 Million
₩-805.47 Million
≈ $-545.86K
-0.001x -110.87%
2015-12-31 ₩1.31 Trillion
≈ $885.99 Million
₩7.04 Billion
≈ $4.77 Million
0.005x -88.35%
2014-12-31 ₩1.18 Trillion
≈ $800.39 Million
₩54.54 Billion
≈ $36.96 Million
0.046x +189.06%
2013-12-31 ₩1.10 Trillion
≈ $745.23 Million
₩17.57 Billion
≈ $11.91 Million
0.016x -57.76%
2012-12-31 ₩972.83 Billion
≈ $659.27 Million
₩36.80 Billion
≈ $24.94 Million
0.038x -70.84%
2011-12-31 ₩895.76 Billion
≈ $607.04 Million
₩116.18 Billion
≈ $78.73 Million
0.130x -69.37%
2010-12-31 ₩839.83 Billion
≈ $569.14 Million
₩355.62 Billion
≈ $241.00 Million
0.423x -54.13%
2009-12-31 ₩522.78 Billion
≈ $354.28 Million
₩482.60 Billion
≈ $327.05 Million
0.923x +93.20%
2008-12-31 ₩350.47 Billion
≈ $237.51 Million
₩167.47 Billion
≈ $113.49 Million
0.478x -36.16%
2007-12-31 ₩351.08 Billion
≈ $237.92 Million
₩262.77 Billion
≈ $178.07 Million
0.748x +59.53%
2006-12-31 ₩221.73 Billion
≈ $150.26 Million
₩104.03 Billion
≈ $70.50 Million
0.469x +78.48%
2005-12-31 ₩236.96 Billion
≈ $160.59 Million
₩62.29 Billion
≈ $42.22 Million
0.263x -69.80%
2003-12-31 ₩210.22 Billion
≈ $142.46 Million
₩182.96 Billion
≈ $123.99 Million
0.870x +648.32%
2001-12-31 ₩273.93 Billion
≈ $185.64 Million
₩31.86 Billion
≈ $21.59 Million
0.116x -39.13%
2000-12-31 ₩282.15 Billion
≈ $191.21 Million
₩53.91 Billion
≈ $36.53 Million
0.191x --

About Green Cross

KO:005250 Korea Biotechnology
Market Cap
$425.10 Million
₩627.28 Billion KRW
Market Cap Rank
#13382 Global
#447 in Korea
Share Price
₩13960.00
Change (1 day)
+0.43%
52-Week Range
₩13330.00 - ₩17200.00
All Time High
₩51630.05
About

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more